Postdural Puncture Headache

Introduction

• PDPH is defined as a headache occurring within 5 days of a dural puncture, caused by cerebrospinal fluid (CSF) leakage through the dural puncture.^1,2
• The incidence is less than 2% after spinal anesthesia with small-gauge pencil-point needles but up to 30–40% following inadvertent dural puncture with a large-bore epidural (Tuohy) needle.¹
• Approximately 65%-98% of patients experience relief with a single blood patch, and 90% of patients who do not respond to the initial blood patch obtain relief with a second.^1,3,4
• Headaches following spinal needle dural puncture can resolve on their own within 2 weeks; those due to Touhy needle usage can persist longer. The impact these headaches can have on daily life, especially for postpartum patients with newborns, can be significant.
• Severe, persistent, or atypical headache following neuraxial anesthesia should prompt immediate evaluation for intracranial pathology (subdural hematoma [SDH], cerebral sinus venous thrombosis, meningitis, preeclampsia).^1,5
• Early recognition and EBP significantly reduce the risk of chronic headache and neurologic complications.
  PDPH Pathophysiology
• Dural puncture can cause a CSF leak into the epidural space through the dural hole, which usually depends on the needle gauge size and can result in low intracranial CSF volume or intracranial hypotension.
  • The larger the needle gauge, the more likely it is for PDPH to occur.
• Symptomatic dural puncture is often caused by accidentally advancing the Touhy needle through the epidural space into the subdural space.
  • This is called a “wet tap” when there is visible CSF coming out of the Touhy needle as the introducer needle is removed.
  • PDPH can also occur after a seemingly uncomplicated epidural placement, likely due to the needle tip puncturing through the dura during placement attempts.
• Headache is thought to result from traction on pain-sensitive structures in the cranium (meninges, dura mater, tentorium) and from intracranial compensatory vasodilation.⁵
  • Intracranial compensatory vasodilation results from a decrease in CSF volume, which triggers cerebral vasodilation (per the Monro–Kellie doctrine) to maintain intracranial volume, increasing vascular distension and traction on pain-sensitive meninges and dura, thereby intensifying headache symptoms.^2,5
• Symptoms of intracranial hypotension happen when the rate of CSF loss exceeds the rate at which CSF can be produced in the choroid plexus.

• Procedural risk factors for PDPH:
  • Larger-gauge needles, cutting-point needles (e.g., Quincke), are at a higher risk than pencil-point needles (e.g., Whitacre, Sprotte, Gertie-Marx) for causing PDPH.^1,3
  • Evidence suggests an association between the number of attempts and the likelihood of developing PDPH.^1,5
  • Higher operator experience reduces the incidence of PDPH.

PDPH Symptoms and Diagnosis

Symptoms

• Headache characteristics: Typically postural—worsening when upright and improving when supine—due to intracranial hypotension
• Distribution: Bilateral frontal, occipital, or retro-orbital pain, often radiating to the neck and shoulders
• Associated symptoms: Neck stiffness, nausea, dizziness, photophobia, or auditory changes (tinnitus, hearing loss)
• Cranial nerve involvement: Traction on cranial nerves—most commonly abducens (CN VI)—may cause diplopia
• Onset and course: Usually begins within 12–72 hours of dural puncture but can occur immediately or be delayed up to 5 days^2,4,5

Diagnosis

• Clinical diagnosis: Based on recent dural puncture and characteristic postural headache
• Imaging: MRI may reveal findings of low intracranial pressure (ICP), including pachymeningeal enhancement, brain sagging, or CSF collection. Imaging is typically reserved for atypical, persistent, or severe cases.^4,5
• Differential diagnosis: Consider preeclampsia/eclampsia, migraine, meningitis, cerebral venous sinus thrombosis (CVST), intracranial hemorrhage, and tension headache
• ICP measurements: Opening or closing pressures are not reliably different from normal and are not diagnostic.⁴

Conservative Management

Overview

• For mild PDPH symptoms that do not interfere with activities of daily living, conservative management is reasonable for the first 24–48 hours.
• Patients should be counseled that symptoms may persist for several days and that an earlier EBP may be indicated if the headache is disabling or refractory.

Positioning

• Supine or recumbent positioning decreases hydrostatic pressure across the dural defect, reducing CSF leakage and symptom severity.
• Prolonged bed rest is not routinely recommended, as mobility supports postpartum recovery and newborn care.
  Analgesics and supportive therapy
• Nonopioid analgesics (acetaminophen, nonsteroidal anti-inflammatory drugs) are first-line therapy for headache and back pain relief.
• Adequate hydration helps maintain CSF production and prevents dehydration-related headaches. No evidence supports excessive intravenous (IV) fluid therapy beyond maintenance needs.
• Antiemetics may be used for symptomatic nausea or vertigo.

Caffeine Therapy

• Caffeine acts as a cerebral vasoconstrictor, mitigating vasodilation from intracranial hypotension.
• Typical dosing: 300–500 mg per os or IV (maximum 900 mg/24 h, avoiding multiple caffeine sources)2
• Benefits are transient, and evidence quality is moderate to low.
• Caffeine should be used cautiously in breastfeeding patients and those with cardiac arrhythmias or seizure history.⁵

Other Pharmacologic Options

• Agents such as gabapentin, theophylline/aminophylline, cosyntropin, hydrocortisone, and neostigmine/atropine have limited supporting evidence and are not routinely recommended.⁴
• These may be considered in refractory cases when EBP is contraindicated or declined, ideally after consultation with anesthesia or neurology.

Bowel Regimen

• Stool softeners and a soft diet minimize straining and ICP spikes that may worsen CSF leakage.

Patient Education

• Patients should be counseled on expected symptom trajectory, warning signs of worsening headache, neurologic changes, or atypical features.
• Follow-up should be encouraged if symptoms persist beyond 24–48 hours or interfere with maternal-infant care, as these warrant consideration of EBP.^4,5

PDPH Complications and Sequelae

Persistent or Chronic Headache

• Up to 20% of patients experience chronic or recurrent headaches following PDPH.^1,5
• Mechanisms may include persistent CSF leak, central sensitization, or altered intracranial compliance.
• Early diagnosis and timely EBP reduce chronicity risk.

Back Pain

• Common and usually self-limited, related to tissue trauma, local inflammation, or reflex muscle spasm from needle passage.
• Backache after EBP typically resolves within a few days.

Cranial Nerve Dysfunction

• Cranial nerve VI (abducens) is most frequently affected, causing diplopia from traction.
• Less commonly, cranial nerves VIII (hearing loss, tinnitus) or III (ptosis, blurred vision) may be involved.⁴
• Most deficits resolve with closure of the CSF leak.

SDH

• Due to downward “brain sagging” and traction on bridging veins in the setting of low ICP
• SDH presents with nonpostural or progressive headache, altered mental status, or focal neurologic deficits.
• SDH requires urgent neuroimaging and neurosurgical consultation.

CVST

• CVST is hought to occur from cerebral venous dilation and postpartum hypercoagulability in the setting of intracranial hypotension.
• CVST presents with worsening or atypical headache, seizures, or neurologic deficits.
• Diagnosis is confirmed by MR venography; treatment includes anticoagulation and management of intracranial hypotension.^4,5

Other Rare Sequelae

• Meningeal fibrosis or arachnoiditis (after multiple punctures or repeated EBP)
• Infection or radiculopathy (rare complications of EBP)^3,5
• Rebound intracranial hypertension after rapid CSF pressure restoration with EBP

Maternal and Functional Impact

• PDPH interferes with maternal mobility, breastfeeding, and newborn care.
• It is associated with delayed postpartum recovery, increased readmission, and higher rates of depression or anxiety if prolonged or inadequately managed.

EPB

• An EBP is the definitive treatment for moderate to severe PDPH.^1,2,4 It provides rapid and often complete symptom relief by restoring ICP and sealing the dural leak.
• Indications for EBP
  • Headache severe enough to impair daily function, ambulation, or newborn care
  • Failure of conservative management after 24–48 hours^2,4
  • Confirmed or strongly suspected dural puncture associated with classic postural headache
  • May be considered earlier for high-risk postpartum patients who cannot tolerate prolonged bed rest
• Timing of EBP
  • Most effective when performed >24 hours after dural puncture, once the inflammatory response and clotting potential optimize sealing
  • Performing the EBP too early (<24 h) carries a higher failure rate
  • Repeat EBP can be offered if symptoms persist after 24 hours, with reported cumulative success rates up to 90–95%^1-4
• Mechanism of Action

• Technique
  • EPB should be performed under strict aseptic conditions at or below the level of dural puncture
  • Up to 20 mL of autologous blood should be injected slowly into the epidural space until the patient feels pressure or discomfort.
  • Smaller volumes (10–15 mL) may be considered for spinal needle punctures, smaller patients, or patients who report continued discomfort with injection.
  • The patient should remain supine for 1–2 hours after the procedure to promote clot formation and leak sealing.⁴
  • Analgesic effect is often immediate; mild back pain is common for 24–48 hours.
• Contraindications to EBP
  • Refusal or inability to cooperate
  • Infection at the puncture site or systemic sepsis
  • Coagulopathy or anticoagulant therapy
  • Suspected intracranial pathology (e.g., mass lesion, SDH)
  • Unclear diagnosis (nonpositional or atypical headache)
• Efficacy of EBP
  • Success rate: 65–98% after the first patch; 90% after a second patch
  • Partial relief occurs in up to one-third of patients; recurrence warrants reevaluation for alternative pathology.
  • Prophylactic EBP (immediately after wet tap) is not recommended, as not all patients develop PDPH, and risks may outweigh benefits.^1,2,4
• Complications

• Post EBP procedural care
  • Patients should be monitored for resolution of headache, new neurological symptoms, or signs of infection.
  • Patients should avoid heavy lifting or Valsalva for 24 hours.
  • If there is no improvement after 24 hours, repeating the EBP or imaging to exclude SDH or CVST should be considered.
  • Clinicians should follow up with the patient for at least 72 hours after the EBP.^2,4
• Early recognition and timely EBP improve postpartum recovery, decrease readmissions, and reduce the risk of chronic headache.
• Prophylactic EBPs are not indicated, but early therapeutic EBPs should be considered in patients with function-limiting PDPH.